Global forum discusses worldwide research, treatment for bleeding disorders, and advancement of patient care
BEDFORD, Mass., November 12, 2019 – rHEALTH LLC will be presenting its transformative Diagnose Yourself, AnywhereTM point-of-care solution for FVIII at the World Federation of Hemophilia (WFH) 11th Global Forum for Research and Treatment Product for Bleeding Disorders. The rHEALTH solution for FVIII is able to take a tiny blood sample (< 20 µL) and provide a result in 15 minutes for a patient or medical provider via its app-driven, Bluetooth connected interface. Conventional central lab FVIII testing require large machines, significant sample preparation, and technician time. Furthermore, results between central labs have a significant discrepancy.
“We are very pleased to be invited by WFH to present our FVIII solution for home and in-office measurement of FVIII levels. Our approach provides a high-level of accuracy for FVIII measurements, particularly for long-acting and gene therapy-based FVIII therapies where conventional testing via activated partial thromboplastin time is less appropriate,” said Dr. Eugene Y. Chan, CEO.
rHEALTH is currently selling its CE-marked FVIII Fluorogenic Assay Kit in English-speaking countries in Europe. This assay is a two-stage assay, similar to the two-stage chromogenic FVIII assay, except that it utilizes a proprietary and highly active, fluorogenic peptide. This approach allows a single range of measurement from < 1% to 200% FVIII levels. The rHEALTH point-of-care solution uses this patent pending two-stage biochemistry to provide high accuracy in measurement of FVIII levels in the presence of interferents such as lupus anti-coagulant and for early detection of inhibitors. The solution is uniquely suitable for patients where such testing is unavailable.
The forum will be in the Westin Hotel in Montreal on November 13-14, 2019 and will address issues related to the safety and supply of treatment products for bleeding disorders, and bring together patient groups, regulators, representatives from industry, and not-for-profit fractionators, as well as doctors who treat people with bleeding disorders. rHEALTH’s talk with be on November 13, 2019 at 3:00 PM EST.
About rHEALTH®
rHEALTH is a company focused on the development and commercialization of its Diagnose Yourself, AnywhereTM technology. rHEALTH’s innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.
Media Contact
Rebecca Yu, (617) 913-7630, pr@rhealth.com